tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market
EYPT
EyePoint Pharmaceuticals
RESEARCH TOOLSreports

EyePoint Pharmaceuticals (EYPT) Income Statement

1,000 Followers

EyePoint Pharmaceuticals Income Statement

Last quarter (Q4 2025), EyePoint Pharmaceuticals's total revenue was $620.00K, a decrease of -94.65% from the same quarter last year. In Q4, EyePoint Pharmaceuticals's net income was $-67.61M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 31.37M$ 43.27M$ 46.02M$ 41.40M$ 36.94M
Gross Profit
$ 29.30M$ 39.56M$ 41.39M$ 33.08M$ 28.76M
Operating Expenses
$ 272.74M$ 185.41M$ 116.45M$ 132.72M$ 84.04M
Depreciation and Amortization
$ 0.00$ 1.54M$ 464.00K$ 2.45M$ 2.77M
EBITDA
$ -243.43M$ -129.23M$ -69.00M$ -96.62M$ -50.15M
Operating Income
$ -243.43M$ -145.85M$ -75.07M$ -99.64M$ -55.28M
Other Income/Expenses
$ 11.75M$ 15.07M$ 4.36M$ -2.62M$ -3.14M
Pretax Income
$ -231.68M$ -130.78M$ -70.71M$ -102.25M$ -58.42M
Net Income
$ -231.96M$ -130.87M$ -70.80M$ -102.25M$ -58.42M
Per Share Metrics
Basic EPS
$ -3.17$ -2.32$ -1.82$ -2.74$ -2.03
Diluted EPS
$ -3.17$ -2.32$ -1.82$ -2.74$ -2.03
Weighted Average Shares Outstanding
 73.25M 56.30M 38.90M 37.32M 28.76M
Weighted Average Shares Outstanding (Diluted)
 73.25M 56.30M 38.90M 37.32M 28.76M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History